#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ovarian epithelial cancer Neuroendocrine carcinoma Primitive neuroectodermal tumour Pulmonary arterial hypertension Thermal burn Obesity Astrocytoma malignant Thrombotic microangiopathy Osteopetrosis Mucous membrane pemphigoid Vaginal cancer Skin cancer Kaposi's sarcoma Usher's syndrome Osteomyelitis More trials…

    Learn about Rare Diseases

    Leukoencephalopathy – Basic Information Primary biliary cholangitis – Trials in Disease Ewing’s sarcoma recurrent – Treatment Systemic mastocytosis – Treatment Testicular leiomyosarcoma – Life with Disease Glomerulonephritis membranoproliferative – Life with Disease Lymphangioma – Basic Information Myelodysplastic syndrome with excess blasts – Diagnostics Mucopolysaccharidosis II – Diagnostics Mucopolysaccharidosis III – Basic Information More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    PF-07868489 Lasmiditan Rigosertib Sodium FLUCLOXACILLIN SODIUM Darolutamide Mavorixafor Alkaline Phosphatase, Bovine Nitrofurantoin RO7268489 Ofatumumab Oritavancin Bupivacaine Hydrochloride Cyclophosphamide Monohydrate Protamine Sulfate Heparin Idarubicin 1,3-BUTYLENE GLYCOL VTX2735 SODIUM ALXN1920 GSKVX000000030918 More therapies…

    Learn about Your Condition

    Anogenital warts Corneal dystrophy Primary hyperoxaluria Ejection fraction normal Andersen-Tawil syndrome Colorectal cancer metastatic Hydrocele ROHHAD syndrome Uveal melanoma Postprandial hypoglycaemia Transient ischaemic attack Urethral stenosis Radicular pain Respiratory distress Onychomycosis More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effects of Acalabrutinib in Patients with Chronic Lymphocytic Leukemia, Richter’s Syndrome, or Prolymphocytic Leukemia

    Not recruiting

    1 1 1 1
    Investigated diseases:
    • Prolymphocytic leukaemia
    • Richter’s syndrome
    • Chronic lymphocytic leukaemia
    Investigated drugs:
    • Acalabrutinib
    Italy

  • Study of Aflibercept 8mg for Patients with Neovascular Age-Related Macular Degeneration Previously Treated with Faricimab and Aflibercept 2mg

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Neovascular age-related macular degeneration
    Investigated drugs:
    • Aflibercept
    Austria

  • Study on Pembrolizumab for Patients with Resectable Metastases from Kidney Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    • Metastatic renal cell carcinoma
    Investigated drugs:
    • Pembrolizumab
    Italy

  • Study of CLN-081 tablets in patients with non-small cell lung cancer with EGFR exon 20 insertion mutations who have previously received platinum chemotherapy

    Not recruiting

    1 1 1
    Investigated diseases:
    • Non-small cell lung cancer metastatic
    • Non-small cell lung cancer recurrent
    Investigated drugs:
    • Cln-081
    Italy The Netherlands Spain

  • Study on the Safety and Effectiveness of Brexucabtagene Autoleucel for Children and Teens with Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma

    Not recruiting

    1 1 1 1
    Investigated diseases:
    • Non-Hodgkin’s lymphoma refractory
    • B-cell type acute leukaemia
    • Non-Hodgkin’s lymphoma
    Investigated drugs:
    • Brexucabtagene Autoleucel
    Czechia France Germany Italy Poland Spain

  • Study of Efgartigimod PH20 SC for Adults with Thyroid Eye Disease

    Not recruiting

    3 1 1
    Investigated diseases:
    • Endocrine ophthalmopathy
    Investigated drugs:
    • Efgartigimod Alfa
    Austria Bulgaria France Germany Italy Latvia +4
Previous Page
1 … 1,157 1,158 1,159 1,160 1,161 … 1,610
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!